# Caffeine Citrate to Improve Neonatal Outcomes.

> **NCT06972849** · NA · NOT_YET_RECRUITING · sponsor: **University of Melbourne** · enrollment: 3900 (estimated)

## Conditions studied

- Apnea of Prematurity

## Interventions

- **DRUG:** Caffeine citrate

## Key facts

- **NCT ID:** NCT06972849
- **Lead sponsor:** University of Melbourne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2029-12
- **Final completion:** 2050-12
- **Target enrollment:** 3900 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06972849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06972849, "Caffeine Citrate to Improve Neonatal Outcomes.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06972849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*